SCHEMBL3683209

SCHEMBL3683209

O=C(O)c1ccc2cccc(C(=O)O)c2c1C(=O)O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 4/20 0.62
KMT2A Q03164 3/20 0.51
ALDH1A1 P00352 3/20 0.51
KDM4E B2RXH2 3/20 0.51
MEN1 O00255 2/20 0.51
TSHR P16473 1/20 0.51
RXFP1 Q9HBX9 1/20 0.51
CYP1A2 P05177 2/20 0.50
NR4A1 P22736 1/20 0.48
NR4A2 P43354 1/20 0.48
NR4A3 Q92570 1/20 0.48
CDC25B P30305 2/20 0.47
WDR5 P61964 1/20 0.46
ALOX15 P16050 1/20 0.44
LDHA P00338 1/20 0.44
KEAP1 Q14145 1/20 0.43
MAPT P10636 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
PTPN1 P18031 1/20 0.42
GLA P06280 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30355326 1.00 HSD17B10 (0.62) HSD17B10KMT2AALDH1A1KDM4EMEN1
SCHEMBL31401777 1.00 HSD17B10 (0.62) HSD17B10KMT2AALDH1A1KDM4EMEN1
SCHEMBL2270685 0.89 HSD17B10 (0.50) HSD17B10KMT2AALDH1A1KDM4EMEN1
SCHEMBL9061414 0.85 HSD17B10 (0.55) HSD17B10KMT2AALDH1A1KDM4EMEN1
SCHEMBL9137723 0.85 CYP1A2 (0.55) HSD17B10KMT2AALDH1A1KDM4EMEN1
SCHEMBL3447012 0.85 CYP1A2 (0.55) HSD17B10KMT2AALDH1A1KDM4EMEN1
SCHEMBL2834703 0.85 HSD17B10 (0.75) HSD17B10KMT2AALDH1A1KDM4EMEN1
SCHEMBL2187678 0.85 HSD17B10 (0.58) HSD17B10KMT2AALDH1A1KDM4EMEN1
SCHEMBL8944544 0.85 KDM4E (0.53) HSD17B10KMT2AALDH1A1KDM4EMEN1
SCHEMBL6471282 0.83 HSD17B10 (0.56) HSD17B10KMT2AALDH1A1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8859806-B2 Process for purification of aryl carboxylic acids UNIVERSITY OF ALABAMA (US) 2014-10-14 US claimed
US-20130068996-A1 PROCESS FOR PURIFICATION OF ARYL CARBOXYLIC ACIDS THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) 2013-03-21 US claimed
US-20100174111-A1 PROCESS FOR PURIFICATION OF ARYL CARBOXYLIC ACIDS UNIVERSITY OF ALABAMA 2010-07-08 US claimed
WO-2008151034-A1 IMPROVED PROCESS FOR PURIFICATION OF ARYL CARBOXYLIC ACIDS THE UNIVERSITY OF ALABAMA (US) 2008-12-11 WO claimed
CN-112500569-B Polyimide precursor composition, polyimide film, laminated film, and display device 武汉柔显科技股份有限公司 2021-05-25 CN disclosed
CN-112500569-A Polyimide precursor composition, polyimide film, laminated film, and display device 武汉柔显科技股份有限公司 2021-03-16 CN disclosed
US-10188992-B2 Polybenzimidazoles and methods of making and using thereof BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2019-01-29 US disclosed
US-20170081477-A1 POLYBENZIMIDAZOLES AND METHODS OF MAKING AND USING THEREOF VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. 2017-03-23 US disclosed
US-8859806-B2 Process for purification of aryl carboxylic acids UNIVERSITY OF ALABAMA (US) 2014-10-14 US disclosed
US-20130068996-A1 PROCESS FOR PURIFICATION OF ARYL CARBOXYLIC ACIDS THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) 2013-03-21 US disclosed
US-8309760-B2 Process for purification of aryl carboxylic acids UNIVERSITY OF ALABAMA (US) 2012-11-13 US disclosed
US-20100174111-A1 PROCESS FOR PURIFICATION OF ARYL CARBOXYLIC ACIDS UNIVERSITY OF ALABAMA 2010-07-08 US disclosed
WO-2008151034-A1 IMPROVED PROCESS FOR PURIFICATION OF ARYL CARBOXYLIC ACIDS THE UNIVERSITY OF ALABAMA (US) 2008-12-11 WO disclosed
EP-0980399-A1 MODIFIED EPOXY RESIN AND ITS USE AS A FORMULATING COMPONENT FOR HEAT-CURABLE COMPOSITIONS, ESPECIALLY FOR POWDER COATINGS Ciba SC Holding AG (CH) 2000-02-23 EP disclosed
WO-1998050447-A1 MODIFIED EPOXY RESIN AND ITS USE AS A FORMULATING COMPONENT FOR HEAT-CURABLE COMPOSITIONS, ESPECIALLY FOR POWDER COATINGS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 1998-11-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170081477-A1 POLYBENZIMIDAZOLES AND METHODS OF MAKING AND USING THEREOF PHB2, SI, NISCH HSD17B10 1477/4885KMT2A 1478/4885ALDH1A1 3432/4885
US-20100174111-A1 PROCESS FOR PURIFICATION OF ARYL CARBOXYLIC ACIDS DDC, AHR, PAH HSD17B10 293/4885KMT2A 1621/4885ALDH1A1 59/4885
US-10188992-B2 Polybenzimidazoles and methods of making and using thereof PHB2, SI, NISCH HSD17B10 1477/4885KMT2A 1478/4885ALDH1A1 3432/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.